Initiative aims to make London Europe’s commercial centre for life sciences
BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g2687 (Published 09 April 2014) Cite this as: BMJ 2014;348:g2687- Nigel Hawkes
- 1London
The mayor of London has launched a new initiative, designed to make the city pre-eminent in the commercialisation of the life sciences, not only in the United Kingdom but in Europe. Called MedCity, it will bring together the expertise of Imperial, University, and King’s colleges of the University of London with Oxford and Cambridge universities to create a “golden triangle” to help turn developments in bioscience into companies and jobs.
The mayor, Boris Johnson, never one to shy away from a historical analogy, compared the initiative to the coming together of the “virtuosi” who launched the scientific revolution in London in the 17th century, meeting in coffee shops and setting up the Royal Society. In recent years, he argued at a launch at Imperial College’s Hammersmith campus, London had not been as successful as some …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.